Unnatural Products

Unnatural Products, Inc. (UNP) is a California-based biotech company with an AI-enhanced chemistry platform that enables a new class of drugs by engineering passively permeable, macrocyclic peptides that access traditionally undruggable targets. Founded by researchers from the University of California Santa Cruz who worked on groundbreaking macrocycle research that underpins the company's platform, the team is made up of brilliant scientists, engineers, and drug developers. UNP has a rapidly growing internal pipeline of assets against some of oncology's toughest and most valuable targets, and is working with select partners on external programs. UNP is privately held and funded by ARTIS Ventures, Abstract Ventures, Asset Management Ventures, Better Ventures, Blue Bear Ventures, Merck Global Health and Innovation Fund, Rising Tide Fund, and Wing VC. For updates and partnering opportunities contact [email protected].